Pirouette Medical (Seed)
Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Valuation
$55,000,000
Company Info
Founders
Conor Cullihane
Market
Healthcare & Wellness
Coinvestors
Asymmetry Ventures,Safar Partners
Company Description

Pirouette is initially developing an epinephrine auto-injector (EAI), which is used for the emergency treatment of severe allergic reactions. Pirouette Medical develops a portable, intuitive, and easy-to-use auto-injector.